A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

Autor: Schöffski, P. *, Reichardt, P., Blay, J.-Y., Dumez, H., Morgan, J.A., Ray-Coquard, I., Hollaender, N., Jappe, A., Demetri, G.D.
Zdroj: In Annals of Oncology October 2010 21(10):1990-1998
Databáze: ScienceDirect